Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06169397 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 67% 94 → 31 participants
See other at-risk trials from Xentria, Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reduced: 94 → 31 participants
    • Trial status changed: Enrolling by Invitation → Active, Not Recruiting
    v14
  2. Primary and study completion moved earlier from Jan 2029 to Nov 2026
    • Secondary endpoints: details revised at 8 of 8 entries
    • Study description expanded, about 26 words
    v13
  3. Study sites: 7 to 11
    • Eligibility criteria expanded, about 18 words
    v12
  4. Study sites: 6 to 7v11
  5. Study sites: 5 to 6v10
Show 8 earlier versionsHide 8 earlier versions
  1. Study sites: 4 to 5v9
  2. Study sites: 3 to 4v8
  3. Study sites: 2 to 3v7
  4. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Mar 2024 to Mar 1, 2024
    v6
  5. Study sites: 1 to 2v5
  6. Study Status, Contacts/Locationsv4
  7. Start date: Jan 2024 to Mar 2024v3
  8. Phase: Phase 3 to Phase 2v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Xentria, Inc.
6 trials monitored
See 3 trials at risk
Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement
Trial Details
NCT Number NCT06169397
Lead Sponsor Xentria, Inc.
Conditions
(from sponsor)		 Pulmonary Sarcoidosis
Related terms Sarcoidosis, Pulmonary
Enrollment 31 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov